Brean Capital Assumes CytoSorbents (CTSO) at Buy
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Brean Capital assumed coverage on CytoSorbents (NASDAQ: CTSO) with a Buy rating and a price target of $24.00.
Shares of CytoSorbents closed at $6.73 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Time Warner (TWX) PT Raised to $102 at Brean Capital
- Jefferies Raises Price Target on FMC Technologies (FTI) After Adjusting Estimates
- Oppenheimer Raises Price Target on Microsoft (MSFT) to $65 Following 1Q Beat
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesBrean Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!